MAPT and Alzheimer disease: Exploration of relationships between CSF p-Tau and non-AD-specific risk factors such as WMH, neurodegeneration, and cognitive decline in individuals who are not yet on the AD pathway provide insight into the heterogeneity of AD and other neurodegenerative diseases.